153 related articles for article (PubMed ID: 33387496)
1. Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
Correa RJM; Palma DA
Lancet Oncol; 2021 Jan; 22(1):6-8. PubMed ID: 33387496
[No Abstract] [Full Text] [Related]
2. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
Abbas G; Danish A; Krasna MJ
Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients.
De Rose F; Cozzi L; Navarria P; Ascolese AM; Clerici E; Infante M; Alloisio M; Testori A; Toschi L; Finocchiaro G; Santoro A; Scorsetti M
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):13-20. PubMed ID: 26385822
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care?
Chapman ER; Correa RJM; Palma DA; Van As N
Clin Oncol (R Coll Radiol); 2022 May; 34(5):318-324. PubMed ID: 35227544
[No Abstract] [Full Text] [Related]
7. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
8. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
[TBL] [Abstract][Full Text] [Related]
11. Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy.
Tsang MW; Kam MK; Leung SF; Chan AT
Hong Kong Med J; 2014 Dec; 20(6):529-36. PubMed ID: 25256817
[TBL] [Abstract][Full Text] [Related]
12. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic ablative radiation therapy for primary lung tumors.
Heinzerling JH; Kavanagh B; Timmerman RD
Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
[TBL] [Abstract][Full Text] [Related]
15. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
16. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
Niazi T; Elakshar S; Stroian G
Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
18. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary atelectasis after stereotactic ablative radiotherapy for a central lung tumor.
Senthi S; Ullmann EF; Senan S
J Thorac Oncol; 2013 Nov; 8(11):e94-5. PubMed ID: 24128724
[No Abstract] [Full Text] [Related]
20. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.
Guerrero E; Ahmed M
Lung Cancer; 2016 Feb; 92():22-8. PubMed ID: 26775592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
